type of glp 1 drugs GLP-1 Drugs: Fighting Diabetes and Weight Gainπ - General New GLP-1 Guidelines for Type
Description
There were two other dual agonists whose sequence has been reported so far, Tyr 1 has been used in MAR709 (designed by Finan et al in 2013, described by numerous other names: DA5-CH, DA-JC1, NNC0090-2746, RG7697, etc.) and His 1 has been used in CY-5 (Figure 3)

Patients seeking GLP-1 therapy should rely on FDA-approved medications with established efficacy profiles, including landmark trials like STEP (semaglutide) demonstrating approximately 15% body weight reduction and SCALE (liraglutide) showing 5-8% weight reduction, along with improved glycemic control in patients with diabetes
The degree of weight loss was independently associated with statistically significant improvements in all NASH-related histologic parameters and provides strong evidence that weight loss is an effective treatment for NAFLD

This medicine has a risk of thyroid C-cell tumors

This study also showed that the people who started GLP-1 treatment had about 33% reduced risk of dementia than those who didnt take these drugs
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)